Literature DB >> 20038820

The molecular pathogenesis of head and neck cancer.

Jonah D Klein1, Jennifer R Grandis.   

Abstract

Head and neck cancer arises from a series of molecular alterations progressive from dysplasia to carcinoma in situ, and finally invasive carcinoma. Risk factors associated with head and neck cancer include tobacco, alcohol and viral infection. There are genetic alterations in pre-cancerous cells that contribute to transformation. The accumulation of these alterations facilitates tumor development. Additionally, the tumor microenvironment enables tumor progression. The cooperative effect of molecular alterations in the tumor cells and compensatory microenvironment changes enable tumors to invade and metastasize. This review focuses on the genes and molecules altered during the progression of head and neck cancer with an emphasis on the genetic, molecular and phenotypic changes during the pathogenesis of head and neck cancer. Therapeutic strategies that target key changes in the tumor cells and/or stromal cells in the tumor microenvironment are discussed.

Entities:  

Mesh:

Year:  2010        PMID: 20038820      PMCID: PMC3138532          DOI: 10.4161/cbt.9.1.10905

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  68 in total

Review 1.  Head and neck cancer: an evolving treatment paradigm.

Authors:  David M Cognetti; Randal S Weber; Stephen Y Lai
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

2.  Identification of oral cancer cell-induced changes in gene expression profile of lymphatic endothelial cell.

Authors:  Zhang Zhuang; Pan Jian; Li Longjiang; Han Bo; Zhao Hongwei
Journal:  Cancer Invest       Date:  2008-12       Impact factor: 2.176

3.  Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma.

Authors:  Thomas K Hoffmann; Eniko Sonkoly; Ulrich Hauser; Anke van Lierop; Theresa L Whiteside; Jens Peter Klussmann; Dieter Hafner; Patrick Schuler; Ulrike Friebe-Hoffmann; Kathrin Scheckenbach; Kaisa Erjala; Reidar Grénman; Jörg Schipper; Henning Bier; Vera Balz
Journal:  Oral Oncol       Date:  2008-05-19       Impact factor: 5.337

Review 4.  Evolution of bevacizumab-based therapy in the management of breast cancer.

Authors:  Jasgit C Sachdev; Mohammad Jahanzeb
Journal:  Clin Breast Cancer       Date:  2008-10       Impact factor: 3.225

5.  Dual silencing of epidermal growth factor and insulin-like growth factor 1 receptors significantly limits growth of nasopharyngeal carcinoma in nude mice.

Authors:  X Zhou; Y Yuan; J Song; W Chen; J Li; L Ye; X Meng; D Xia
Journal:  J Laryngol Otol       Date:  2008-05-01       Impact factor: 1.469

6.  p73 G4C14-to-A4T14 polymorphism and risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never smokers and never drinkers.

Authors:  Xingming Chen; Erich M Sturgis; Carol J Etzel; Qingyi Wei; Guojun Li
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

7.  A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis.

Authors:  Steven Clasper; Daniel Royston; Dilair Baban; Yihai Cao; Stephan Ewers; Stefan Butz; Dietmar Vestweber; David G Jackson
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

Review 8.  Molecular pathogenesis of head and neck cancers.

Authors:  Bhuvanesh Singh
Journal:  J Surg Oncol       Date:  2008-06-15       Impact factor: 3.454

Review 9.  Systems biology of vascular endothelial growth factors.

Authors:  Feilim Mac Gabhann; Aleksander S Popel
Journal:  Microcirculation       Date:  2008-11       Impact factor: 2.628

10.  Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma.

Authors:  Carmen J Marsit; Brock C Christensen; E Andres Houseman; Margaret R Karagas; Margaret R Wrensch; Ru-Fang Yeh; Heather H Nelson; Joseph L Wiemels; Shichun Zheng; Marshall R Posner; Michael D McClean; John K Wiencke; Karl T Kelsey
Journal:  Carcinogenesis       Date:  2009-01-06       Impact factor: 4.944

View more
  29 in total

1.  The pivotal role of integrin β1 in metastasis of head and neck squamous cell carcinoma.

Authors:  Dongsheng Wang; Susan Müller; A R M Ruhul Amin; Donghai Huang; Ling Su; Zhongliang Hu; Mohammad Aminur Rahman; Sreenivas Nannapaneni; Lydia Koenig; Zhengjia Chen; Mourad Tighiouart; Dong M Shin; Zhuo G Chen
Journal:  Clin Cancer Res       Date:  2012-07-24       Impact factor: 12.531

2.  Deubiquitylating enzyme, USP9X, regulates proliferation of cells of head and neck cancer lines.

Authors:  D M Nanayakkara; M N Nguyen; S A Wood
Journal:  Cell Prolif       Date:  2016-07-04       Impact factor: 6.831

3.  Clinicopathological characteristics and cell cycle proteins as potential prognostic factors in myoepithelial carcinoma of salivary glands.

Authors:  F Passador-Santos; M Grönroos; J Irish; R Gilbert; P Gullane; B Perez-Ordonez; A Mäkitie; I Leivo
Journal:  Virchows Arch       Date:  2015-12-28       Impact factor: 4.064

4.  MAPK/ERK-dependent translation factor hyperactivation and dysregulated laminin γ2 expression in oral dysplasia and squamous cell carcinoma.

Authors:  Martin Degen; Easwar Natarajan; Patricia Barron; Hans R Widlund; James G Rheinwald
Journal:  Am J Pathol       Date:  2012-04-28       Impact factor: 4.307

Review 5.  Precision Therapy of Head and Neck Squamous Cell Carcinoma.

Authors:  P J Polverini; N J D'Silva; Y L Lei
Journal:  J Dent Res       Date:  2018-04-12       Impact factor: 6.116

6.  Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma.

Authors:  Jesse D Troy; Joel L Weissfeld; Ada O Youk; Sufi Thomas; Lin Wang; Jennifer R Grandis
Journal:  Head Neck Pathol       Date:  2013-05-04

7.  Molecular mechanisms of anti-tumor properties of P276-00 in head and neck squamous cell carcinoma.

Authors:  Prabha B Mishra; Aurelio S Lobo; Kalpana S Joshi; Maggie J Rathos; Gopinath A Kumar; Muralidhara Padigaru
Journal:  J Transl Med       Date:  2013-02-18       Impact factor: 5.531

8.  Receptor-tyrosine-kinase-targeted therapies for head and neck cancer.

Authors:  Lisa A Elferink; Vicente A Resto
Journal:  J Signal Transduct       Date:  2011-06-07

9.  RSK activation of translation factor eIF4B drives abnormal increases of laminin γ2 and MYC protein during neoplastic progression to squamous cell carcinoma.

Authors:  Martin Degen; Patricia Barron; Easwar Natarajan; Hans R Widlund; James G Rheinwald
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

10.  Gastro-duodenal fluid induced nuclear factor-κappaB activation and early pre-malignant alterations in murine hypopharyngeal mucosa.

Authors:  Dimitra P Vageli; Manju L Prasad; Clarence T Sasaki
Journal:  Oncotarget       Date:  2016-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.